论文部分内容阅读
目的探讨沙丁胺醇联合异丙托溴铵治疗儿童哮喘的临床疗效。方法 92例儿童哮喘患者随机分为沙丁胺醇组、异丙托溴铵组和联用组,在其他治疗措施相同的基础上,29例沙丁胺醇组患者单用沙丁胺醇雾化吸入,30例异丙托溴铵组患者单用异丙托溴铵雾化吸入,33例联用组患者联用沙丁胺醇与异丙托溴铵雾化吸入,比较三组哮喘患儿的哮喘控制率。结果联用组控制率高于沙丁胺醇组和异丙托溴铵组,差异有统计学意义(P<0.05)。结论沙丁胺醇联合异丙托溴铵雾化吸入治疗儿童哮喘,药效协同,疗效显著,该做法值得临床推广。
Objective To investigate the clinical efficacy of salbutamol combined with ipratropium bromide in the treatment of childhood asthma. Methods Ninety-two children with asthma were randomly divided into salbutamol group, ipratropium bromide group and combination group. On the basis of other treatment measures, 29 patients in salbutamol group were treated with salbutamol inhalation alone and 30 ipratropium bromide Patients in the ammonium group were inhaled with ipratropium bromide alone. 33 patients in combination group were treated with atomization inhalation of albuterol and ipratropium bromide, and asthma control rates were compared between the three groups. Results The combined control group was higher than salbutamol group and ipratropium bromide group, the difference was statistically significant (P <0.05). Conclusion Salbutamol combined with ipratropium bromide inhalation treatment of childhood asthma, synergistic effect, the effect is significant, the practice worthy of clinical promotion.